rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
35
|
pubmed:dateCreated |
2001-3-29
|
pubmed:abstractText |
To evaluate the HGV infection prevalence in a group of intravenous drug users with or without human immunodeficiency virus coinfection.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0172-6390
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1385-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11100358-Adult,
pubmed-meshheading:11100358-Female,
pubmed-meshheading:11100358-Flaviviridae,
pubmed-meshheading:11100358-HIV Infections,
pubmed-meshheading:11100358-Hepacivirus,
pubmed-meshheading:11100358-Hepatitis, Viral, Human,
pubmed-meshheading:11100358-Hepatitis B Surface Antigens,
pubmed-meshheading:11100358-Humans,
pubmed-meshheading:11100358-Male,
pubmed-meshheading:11100358-Prevalence,
pubmed-meshheading:11100358-RNA, Viral,
pubmed-meshheading:11100358-Substance Abuse, Intravenous
|
pubmed:articleTitle |
Hepatitis G virus infection in intravenous drug users with or without human immunodeficiency virus infection.
|
pubmed:affiliation |
Department of Internal Medicine, University of Genoa, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|